Manufacturer:
Salix Pharmaceuticals
Route of Administration:
Oral, Subcutaneous
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- [tablets and injection] treatment of opioid-induced constipation in adults with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation
- [injection] treatment of opioid-induced constipation in adult with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care
Conditions:
- Opioid-Induced Constipation (OIC)
Therapeutic Area:
- Gastroenterology